News Image

Aclarion Announces Use of MR Spectroscopy for identifying Biomarkers of Discogenic Pain highlighted at Global Neuroscience Conference

Provided By GlobeNewswire

Last update: Oct 13, 2025

Panel discussion featured at the International Society of Pain and Neuroscience (ISPN) Annual Meeting in London titled United to Conquer Pain

Session Co-Moderator Doug Beall, M.D. underscored that disc chemistry is the critical biomarker for diagnosing the leading cause of chronic low back pain

Read more at globenewswire.com

ACLARION INC

NASDAQ:ACON (10/15/2025, 8:12:55 PM)

Premarket: 9.08 -0.02 (-0.22%)

9.1

+0.15 (+1.68%)


ACLARION INC -CW27

NASDAQ:ACONW (10/15/2025, 8:12:55 PM)

0.0553

0 (-3.15%)



Find more stocks in the Stock Screener

Follow ChartMill for more